An Indian-origin expert at the University of Colorado Denver has shed light on why an inhaled insulin product turned out to be a commercial failure.
Dr. Satish K. Garg, a professor of Medicine and Pediatrics at the University of Colorado Denver, says that the results of a 2-year Phase 3 trial conducted in 385 patients suggest that AIR inhaled insulin was inferior to SC insulin in its ability to maintain optimal blood glucose levels over time, based on measurements of glycosylated hemoglobin (HbA1c).
Insulin Delivery Devices
Insulin delivery devices have evolved drastically since their invention in 1922. They are all aimed to provide insulin to the patients with minimal discomfort.
Advertisement
Similarly, another study on 500 patients with type 1 diabetes showed inferiority of AIR in a 6-month trial.
"The question now remains whether this route of delivering insulin has been exhausted or if it still remains to be explored," writes Dr. Satish Garg, who is also the Editor-in-Chief of Diabetes Technology and Therapeutics, and William Kelly, from the University of Colorado Denver.
![Diabetes - Self-Monitoring of Blood Glucose (SMBG)]( "Diabetes - Self-Monitoring of Blood Glucose (SMBG)")
Self-Monitoring Of Blood Glucose (SMBG) is one of the greatest advancements in the management of Diabetes.
An editorial titled 'Insulin Delivery via Lungs-Is It Still Possible?' says that a company called MannKind Corporation has recently filed a New Drug Application with the Food and Drug Administration (FDA) for Technosphere Insulin.
It offers faster onset of action with lower postprandial blood glucose excursions especially in the first two hours and is weight neutral, according to the Editorial.
Source: ANI
SRM
Diabetes - Self-Monitoring of Blood Glucose (SMBG)
Self-Monitoring Of Blood Glucose (SMBG) is one of the greatest advancements in the management of Diabetes.
Advertisement
An editorial titled 'Insulin Delivery via Lungs-Is It Still Possible?' says that a company called MannKind Corporation has recently filed a New Drug Application with the Food and Drug Administration (FDA) for Technosphere Insulin.
It offers faster onset of action with lower postprandial blood glucose excursions especially in the first two hours and is weight neutral, according to the Editorial.
Source: ANI
SRM
Quiz on Diabetes
Diabetes has replaced every other condition to become the fastest growing lifestyle disease, globally. This disease also impacts children. Some people are more inclined to develop diabetes than others. Do you belong to the high- risk group? Spend 5 minutes to find out.
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Diabetes News
The US Food and Drug Administration (FDA) clears the 'bionic pancreas' that improves the management of type 1 diabetes, without the need for constant blood sugar testing.
A new study investigated the use of a mathematical model of glucose metabolism to assess continuous glucose monitor data as a metric of dysfunctional glycemic control.
At least 400 medicinal plants effective in decreasing sugar levels in the blood which is critical to control type 2 diabetes identified.
Considering the enormous type 2 diabetes patient population in China, a new oral insulin therapy will improve treatment.
The use of biodegradable “nanoscavengers” to restore insulin sensitivity and treat type 2 diabetes has been discovered.